NUWENuwellis, Inc.

Nasdaq nuwellis.com


$ 4.02 $ 0.04 (0.98 %)    

Wednesday, 03-Jul-2024 12:59:35 EDT
QQQ $ 490.95 $ 4.06 (0.83 %)
DIA $ 392.84 $ -0.46 (-0.12 %)
SPY $ 551.46 $ 2.45 (0.45 %)
TLT $ 91.86 $ 1.19 (1.31 %)
GLD $ 217.99 $ 2.43 (1.13 %)
$ 4.12
$ 4.15
$ 0.00 x 0
$ 4.10 x 100
$ 3.85 - $ 4.15
$ 3.80 - $ 98.35
96,444
na
739,987
$ 0.91
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 03-11-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 03-03-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 03-03-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
13 05-13-2021 03-31-2021 10-Q
14 03-25-2021 12-31-2020 10-K
15 11-12-2020 09-30-2020 10-Q
16 08-05-2020 06-30-2020 10-Q
17 05-14-2020 03-31-2020 10-Q
18 03-05-2020 12-31-2019 10-K
19 11-08-2019 09-30-2019 10-Q
20 08-08-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
22 02-21-2019 12-31-2018 10-K
23 11-07-2018 09-30-2018 10-Q
24 08-09-2018 06-30-2018 10-Q
25 05-10-2018 03-31-2018 10-Q
26 03-22-2018 12-31-2017 10-K
27 11-02-2017 09-30-2017 10-Q
28 08-10-2017 06-30-2017 10-Q
29 05-12-2017 03-31-2017 10-Q
30 03-08-2017 12-31-2016 10-K
31 11-14-2016 09-30-2016 10-Q
32 08-11-2016 06-30-2016 10-Q
33 05-05-2016 03-31-2016 10-Q
34 03-15-2016 12-31-2015 10-K
35 11-05-2015 09-30-2015 10-Q
36 08-05-2015 06-30-2015 10-Q
37 05-07-2015 03-31-2015 10-Q
38 03-20-2015 12-31-2014 10-K
39 10-31-2014 09-30-2014 10-Q
40 08-12-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 nuwellis-granted-patent-from-us-patent-and-trademark-office-relate-to-pediatric-continuous-renal-replacement-therapy-vivian

This patent covers critical advancements that will significantly improve the performance and user experience of Vivian. This is...

 nuwellis-granted-us-patent-11986584-today-for-extracorporeal-blood-filtering-machine-and-methods

https://ppubs.uspto.gov/dirsearch-public/print/downloadPdf/11986584

 nuwellis-q1-2024-gaap-eps-060-beats-106-estimate-sales-190m-miss-200m-estimate

Nuwellis (NASDAQ:NUWE) reported quarterly losses of $(0.60) per share which beat the analyst consensus estimate of $(1.06) by 4...